Sensei biotherapeutics appoints patrick gallagher, mba, mph, as chief business officer

Boston, june 01, 2022 (globe newswire) -- sensei biotherapeutics, inc. (nasdaq: snse), an immunotherapy company focused on the discovery and development of next-generation therapeutics for cancer, today announced the appointment of patrick gallagher, mba, mph, as chief business officer.
SNSE Ratings Summary
SNSE Quant Ranking